Well, that brings our open hearing to a conclusion. We're only 10 minutes late. I did make a statistical analysis and the M.D.s took 4.3 minutes to do their presentations and the Ph.D.s took 10.8 and I think there's a correlation in there somewhere.
DR. KIBBE: But let me assure everyone who came that we do not take this situation lightly. We will take into account all of the information that was presented to us and supplement it with additional information that we can get from valid scientific sources and certainly it will be a high priority item for our Biopharmaceutics Subcommittee to look at. We really do appreciate your interest and your efforts on behalf of the American public.
And I think we now stand adjourned for lunch. We're going to open up again at 1:30 with bioequivalency and continue the discussion on endogenous drug substances.
(Whereupon, at 12:40 p.m., the committee was recessed, to reconvene at 1:30 p.m., this same day.)